Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE].


Journal

Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676

Informations de publication

Date de publication:
05 Mar 2021
Historique:
pubmed: 25 9 2020
medline: 3 11 2021
entrez: 24 9 2020
Statut: ppublish

Résumé

Better patient knowledge on inflammatory bowel disease [IBD] could improve outcome and quality of life. The aim of this study was to assess if an education programme improves IBD patients' skills as regards their disease. The GETAID group conducted a prospective multicentre randomised controlled study. IBD patients were included at diagnosis, or after a significant event in the disease course. Patients were randomised between 'educated' or control groups for 6 months. Education was performed by trained health care professionals. A psycho-pedagogic score [ECIPE] was evaluated by a 'blinded' physician at baseline and after 6 and 12 months [M6 and M12]. The primary endpoint was the increase of ECIPE score at M6 of more than 20%. A total of 263 patients were included in 19 centres (male:40%; median age:30.8; Crohn's disease [CD]:73%). Of these, 133 patients were randomised into the educated group and 130 into the control group. The median relative increase in ECIPE score at M6 was higher in the educated group as compared with the control group (16.7% [0-42.1%] vs 7% [0-18.8%], respectively, p = 0.0008). The primary endpoint was met in 46% vs 24% of the patients in the educated and control groups, respectively [p = 0.0003]. A total of 92 patients met the primary endpoint. In multivariate analysis, predictors of an increase of at least 20% of the ECIPE score were randomisation in the educated group (odds ratio [OR] = 2.59) and no previous surgery [OR = 1.92]. These findings support the set-up of education programmes in centres involved in the management of IBD patients.

Sections du résumé

BACKGROUND BACKGROUND
Better patient knowledge on inflammatory bowel disease [IBD] could improve outcome and quality of life. The aim of this study was to assess if an education programme improves IBD patients' skills as regards their disease.
METHODS METHODS
The GETAID group conducted a prospective multicentre randomised controlled study. IBD patients were included at diagnosis, or after a significant event in the disease course. Patients were randomised between 'educated' or control groups for 6 months. Education was performed by trained health care professionals. A psycho-pedagogic score [ECIPE] was evaluated by a 'blinded' physician at baseline and after 6 and 12 months [M6 and M12]. The primary endpoint was the increase of ECIPE score at M6 of more than 20%.
RESULTS RESULTS
A total of 263 patients were included in 19 centres (male:40%; median age:30.8; Crohn's disease [CD]:73%). Of these, 133 patients were randomised into the educated group and 130 into the control group. The median relative increase in ECIPE score at M6 was higher in the educated group as compared with the control group (16.7% [0-42.1%] vs 7% [0-18.8%], respectively, p = 0.0008). The primary endpoint was met in 46% vs 24% of the patients in the educated and control groups, respectively [p = 0.0003]. A total of 92 patients met the primary endpoint. In multivariate analysis, predictors of an increase of at least 20% of the ECIPE score were randomisation in the educated group (odds ratio [OR] = 2.59) and no previous surgery [OR = 1.92].
CONCLUSIONS CONCLUSIONS
These findings support the set-up of education programmes in centres involved in the management of IBD patients.

Identifiants

pubmed: 32969469
pii: 5910905
doi: 10.1093/ecco-jcc/jjaa195
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

432-440

Investigateurs

Franck Brazier (F)
Jean-Louis Dupas (JL)
Mathurin Fumery (M)
Martine Leconte (M)
Annie Bornet (A)
Yoram Bouhnik (Y)
Geraldine Herbet (G)
Suzanna Ostrec (S)
Carmen Stefanescu (C)
Xavier Treton (X)
Benoît Coffin (B)
Delphine Coutarel (D)
Joséphanne Romarin (J)
Franck Carbonnel (F)
Lysiane Marthey (L)
Valérie Kail (V)
Maria Nachury (M)
Benjamin Pariente (B)
Stéphanie Challier (S)
Mylène Ducerne (M)
Jean-Charles Grimaud (JC)
Isabelle Lutgen (I)
Valérie Lebayle (V)
Laetitia Legoux (L)
Stéphane Nahon (S)
Romain Altwegg (R)
Ludovic Caillo (L)
Laurent Peyrin-Biroulet (L)
Nelly Benard (N)
Béatrice Boucard (B)
Arnaud Bourreille (A)
Elise Kerdreux (E)
Katia Ferreira (K)
Caroline Trang-Poisson (C)
Nadia Arab (N)
Virginie Cluzeau (V)
Evalyne Eyraud (E)
Jerôme Filippi (J)
Xavier Hébuterne (X)
Aurore Paput (A)
Amine Rahill (A)
Laura Armengol-De Beir (L)
Julien Blot (J)
Elise Foloppe (E)
Guillaume Savoye (G)
Gaëlle Vienney (G)
Marion Simon (M)
Laurent Beaugerie (L)
Anne Bourrier (A)
Najim Chafai (N)
Clotilde Debove (C)
Nadia Hoyeau (N)
Julien Kirchgesner (J)
Cécilia Landman (C)
Jérémie H Lefèvre (JH)
Isabelle Nion-Larmurier (I)
Yann Parc (Y)
Philippe Seksik (P)
Harry Sokol (H)
Matthieu Allez (M)
Clotilde Baudry (C)
Joëlle Bonnet (J)
Leïla Chedouba (L)
Nathalie Descrouet (N)
Nassim Hammoudi (N)
Jean-Félix Lepasteur (JF)
Andrée Nisard (A)
Marion Vincent (M)
Sylvie Chevret (S)
Kristell Desseaux (K)
Regine Berolo (R)
Emilie Del Tedesco (E)
Xavier Roblin (X)
Emilie Bergereau (E)
Patrick Faure (P)
Audrey Haenning (A)
Marianne Lassailly (M)
Jacques Moreau (J)
Sandra Orempuller (S)
Bruno Mesnard (B)
Souheyla Mezrag Biskri (SM)
Noémie Tavernier (N)
Floriane Verhaeghe (F)
Gwenola Vernier (G)
Alexandre Aubourg (A)
Magalie Chauvigneau (M)
Charles Lamblin (C)
Marie-Christine Lorin (MC)
Laurence Picon (L)

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

J Moreau (J)

Gastroenterology Department, Hôpital Rangueil, Toulouse, France.

N Hammoudi (N)

Gastroenterology Department, APHP, Hôpital Saint-Louis, INSERM UMRS 1160, Université Paris Diderot, Sorbonne Paris-Cité University, Paris, France.

L Marthey (L)

Gastroenterology Department, Hôpital du Kremlin-Bicetre, Kremlin Bicetre, France.

C Trang-Poisson (C)

Gastroenterology Department, Hotel-Dieu, Nantes, France.

M Nachury (M)

CHU Lille, Maladies de l'appareil digestif, Lille, France.

R Altwegg (R)

Gastroenterology Department, Hôpital St-Eloi, Montpellier, France.

J C Grimaud (JC)

Gastroenterology Department, Hôpital Nord, Marseille, France.

S Orempuller (S)

Gastroenterology Department, Hôpital Rangueil, Toulouse, France.

X Hébuterne (X)

Gastroenterology Department, Hôpital Archet, Nice, France.

A Aubourg (A)

Gastroenterology Department, Hôpital Trousseau, Tours, France.

C Baudry (C)

Gastroenterology Department, APHP, Hôpital Saint-Louis, INSERM UMRS 1160, Université Paris Diderot, Sorbonne Paris-Cité University, Paris, France.

P Seksik (P)

Department of Gastroenterology, Centre de recherche Saint-Antoine, Sorbonne Université, APHP, Hôpital Saint-Antoine, Paris, France.

X Roblin (X)

Gastroenterology Department, Hôpital de St-Etienne, St-Etienne, France.

S Nahon (S)

Gastroenterology Department, Hôpital de Montfermeil, Montfermeil, France.

G Savoye (G)

Gastroenterology Department, Hôpital Charles Nicolle, Rouen, France.

B Mesnard (B)

Gastroenterology Department, Hôpital Dron, Tourcoing, France.

C Stefanescu (C)

Gastroenterology Department, Hôpital Beaujon, Clichy, France.

M Simon (M)

Gastroenterology Department, Institut Mutualiste Monsouris, Paris, France.

B Coffin (B)

Gastroenterology Department, Hôpital Louis Mourier, Colombes, France.

M Fumery (M)

Gastroenterology Department, Hôpital Nord, Amiens, France.

F Carbonnel (F)

Gastroenterology Department, Hôpital du Kremlin-Bicetre, Kremlin Bicetre, France.

L Peyrin-Biroulet (L)

Department of Gastroenterology, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.

K Desseaux (K)

SBIM, Hôpital Saint-Louis, Paris, France.

M Allez (M)

Gastroenterology Department, APHP, Hôpital Saint-Louis, INSERM UMRS 1160, Université Paris Diderot, Sorbonne Paris-Cité University, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH